Generate Biomedicines, Inc. GENB
14.16 USD +0.31 (+2.24%)
At closeNov 5, 2026, 8:01 AM EST
14.30 +0.14 +0.99%
Pre-market · Nov 5, 8:01 AM ET
13.40 Day range 14.34
11.00 52-week range 22.67
- YTD
- +11.94%
- 1 year
- +11.94%
Financial health
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 2
Valuation
P/E -2.5×
FY 2024 5y median -5.0× FY 2025
P/S 19.9×
FY 2024 5y median 49.3× FY 2025
P/B -1.0×
FY 2024 5y median -2.4× FY 2025
P/FCF -3.1×
FY 2024 5y median -8.2× FY 2025
EV/EBITDA -2.8×
FY 2024 5y median -6.0× FY 2025
EV/Sales 18.2×
FY 2024 5y median 46.1× FY 2025
FCF Yield -32.2%
FY 2024 5y median -19.9% FY 2025
Profitability
Gross Margin 100.0%
FY 2024 5y median 100.0% FY 2025
Operating Margin -737.0%
FY 2024 5y median -849.8% FY 2025
Net Margin -637.0%
FY 2024 5y median -743.2% FY 2025
ROE 33.0%
FY 2024 5y median 36.5% FY 2025
ROIC -89.4%
FY 2024 5y median -66.7% FY 2025
ROA -61.5%
FY 2024 5y median -47.5% FY 2025
Growth (YoY)
Revenue 55.9%
FY 2024 FY 2025
Operating Income -19.4%
FY 2024 FY 2025
EPS (diluted) -196.4%
FY 2024 FY 2025
Free Cash Flow -68.4%
FY 2024 FY 2025
Financial Health
Current Ratio 2.9×
FY 2024 5y median 3.8× FY 2025
Quick Ratio 2.9×
FY 2024 5y median 3.8× FY 2025
Debt / Equity -0.1×
FY 2024 5y median -0.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2024 5y median 0.4× FY 2025
Interest Coverage -207×
FY 2024 5y median -150× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31